Lagoda Investment Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MON
Monsanto Co
MON
|
+$10.4M |
| 2 |
Ubiquiti
UI
|
+$5.96M |
| 3 |
VolitionRx Ltd
VNRX
|
+$5.07M |
| 4 |
TTOO
T2 Biosystems, Inc
TTOO
|
+$3.02M |
| 5 |
Digimarc Corp
DMRC
|
+$1.76M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MACK
Merrimack Pharmaceuticals, Inc.
MACK
|
+$1.97M |
| 2 |
NVO
Novo Nordisk
NVO
|
+$1.51M |
| 3 |
Berkshire Hathaway Class A
BRK.A
|
+$439K |
| 4 |
ESGR
Enstar Group
ESGR
|
+$392K |
| 5 |
Mastercard
MA
|
+$330K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 48.15% |
| 2 | Technology | 20.9% |
| 3 | Communication Services | 12.14% |
| 4 | Financials | 9.29% |
| 5 | Materials | 5.38% |
Similar funds
Lagoda Investment Management's Q3 2016 Portfolio in Review
As of Q3 2016, Lagoda Investment Management held 29 positions worth $333M, up 24% from $268M the previous quarter. Its ten largest holdings account for 71% of the portfolio.
Lagoda Investment Management deployed $25.4M of net new capital in Q3 2016, opening 1 new position and adding to 14 existing holdings. Its largest new stake was Berkshire Hathaway Class B: 1,400 shares worth $202K.
By sector, the portfolio is most concentrated in Healthcare at 48% of assets, down from 50% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Merrimack Pharmaceuticals, Inc., an estimated $1.97M trimmed.
- Lagoda Investment Management's largest Q3 2016 buy was Berkshire Hathaway Class B: 1,400 shares worth $202K.
- Lagoda Investment Management added most to Monsanto Co in Q3 2016, an estimated $10.4M increase.
- Lagoda Investment Management's biggest Q3 2016 reduction was Merrimack Pharmaceuticals, Inc., cutting an estimated $1.97M.
- Lagoda Investment Management's ten largest holdings make up 71% of its $333M portfolio in Q3 2016.
- Lagoda Investment Management opened 1 new position and closed 0 in Q3 2016.
- Lagoda Investment Management's portfolio value rose 24% quarter-over-quarter to $333M.
Based on Lagoda Investment Management's 13F filing for Q3 2016, filed 14 Nov 2016.